Corcept Therapeutics (CORT)
(Delayed Data from NSDQ)
$32.87 USD
+1.57 (5.02%)
Updated Jun 4, 2024 04:00 PM ET
After-Market: $32.88 +0.01 (0.03%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth F Momentum C VGM
Brokerage Reports
0 items in cart
Corcept Therapeutics Incorporated [CORT]
Reports for Purchase
Showing records 201 - 220 ( 224 total )
Company: Corcept Therapeutics Incorporated
Industry: Medical - Drugs
Company: Corcept Therapeutics Incorporated
Industry: Medical - Drugs
Company: Corcept Therapeutics Incorporated
Industry: Medical - Drugs
Company: Corcept Therapeutics Incorporated
Industry: Medical - Drugs
Company: Corcept Therapeutics Incorporated
Industry: Medical - Drugs
Company: Corcept Therapeutics Incorporated
Industry: Medical - Drugs
Company: Corcept Therapeutics Incorporated
Industry: Medical - Drugs
Company: Corcept Therapeutics Incorporated
Industry: Medical - Drugs
Company: Corcept Therapeutics Incorporated
Industry: Medical - Drugs
Company: Corcept Therapeutics Incorporated
Industry: Medical - Drugs
Company: Corcept Therapeutics Incorporated
Industry: Medical - Drugs
Company: Corcept Therapeutics Incorporated
Industry: Medical - Drugs
Company: Corcept Therapeutics Incorporated
Industry: Medical - Drugs
Company: Corcept Therapeutics Incorporated
Industry: Medical - Drugs
Company: Corcept Therapeutics Incorporated
Industry: Medical - Drugs
Company: Corcept Therapeutics Incorporated
Industry: Medical - Drugs
Company: Corcept Therapeutics Incorporated
Industry: Medical - Drugs
Company: Corcept Therapeutics Incorporated
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Corcept Therapeutics Incorporated
Industry: Medical - Drugs
Discontinuation of Coverage of the Biotech Sector
Provider: Brinson Patrick Securities Corporation
Company: Corcept Therapeutics Incorporated
Industry: Medical - Drugs
Two Data Readouts in 1H?15; Reiterating Market Outperform
Provider: Brinson Patrick Securities Corporation
Analyst: JAMES C